• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Cerus Corp.

Cerus lands additional $15m in government funding

May 17, 2018 By Sarah Faulkner

Cerus Corp.

Cerus (NSDQ:CERS) landed a $15 million amendment to its contract with the U.S. Dept. of Health & Human Services’ Biomedical Advanced Research and Development Authority, bringing the total potential value of its deal to $201 million. The expanded agreement is designed to support additional clinical trials of the company’s Intercept blood transfusion technology. Cerus’ Phase III […]

Filed Under: Cardiovascular, Clinical Trials, Featured, Funding Roundup, Surgical, Wall Street Beat Tagged With: Cerus Corp.

Medtech stories we missed this week: April 27, 2018

April 27, 2018 By Danielle Kirsh

canyon at sunset

From DuPuy Synthes’s spinal implant launch to Lumendi’s FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. DePuy Synthes launches spinal implants DePuy Synthes announced in an April 26 press release that it has launched its Proti 360º integrated titanium family of interbody devices that are designed to […]

Filed Under: Featured, Food & Drug Administration (FDA), Hematology, Hospital Care, Orthopedics, Regulatory/Compliance Tagged With: abbott, apolloendosurgery, Cerus Corp., DePuy Synthes, lumendi, PAVmed, reshapelifesciences, sanquin

Cerus closes $58m public offering

February 5, 2018 By Fink Densford

Cerus Corp.

Cerus (NSDQ:CERS) said today it closed a $57.5 million public offering, including the sale of additional shares as part of an underwriter’s option. The Concord, Calif.-based company said that the $57.5 million in proceeds does not include the deduction of offering expenses, and did not state how it plans to spend funds raised in the offering. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup Tagged With: Cerus Corp.

Medtech stories we missed this week: August 4, 2017

August 4, 2017 By Danielle Kirsh

missed medtech aug 4

From MDCorp inking a European distribution deal to Align Technology’s North Carolina expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. MDCorp inks distribution deal with Smart Endoscope Systems MDCorp announced in a July 31 press release that it has signed a distribution agreement with Smart Endoscope […]

Filed Under: Featured, Food & Drug Administration (FDA), Imaging, Vascular Tagged With: Access Scientific Inc., aligntechnology, Central California Blood Center, Cerus Corp., FujiFilm Medical Systems, MDCorp, medtech, Smart Endoscope Systems, Standard Bariatric, SuperSonic Imagine S.A.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS